ROLE OF FABP1 AS A DIAGNOSTIC BIOMARKER FOR NON-ALCOHOLIC FATTY PANCREATIC DISEASE

Fatty Acid Binding Protein (1 & 2) as Markers of Diabetic Nephropathy in Elderly Patients with Type 2 Diabetes Mellitus

Role of Some Adipokines in Nonalcoholic Fatty Liver Diseases

Liver Fatty Acid-binding Protein (L-FABP) as a Diagnostic Marker for Non-alcoholic Fatty Liver Disease

ADIPOCYTES FATTY ACID BINDING PROTEIN AND ITS RELATION TO SUBCLNICAL ATHEROSCLEROSIS IN SUBJECTS WITH TYPE 2 DIABETES

Studying the Association between Non Alcoholic Fatty Pancreatic Disease and Non Alcoholic Fatty Liver Disease

Circulating Adipocyte Fatty Acid Binding Protein (A-FABP): Predictor of Metabolic Syndrome in Patients with Type 2DM

Relationship Between Serum Adipocyte Fatty Acid Binding Protein and Atherosclerosis in Type 2 Diabetes Patients

Role of Intestinal Fatty Acid Binding Protein in Treated Inflammatory Bowel Diseases Patients

Prognostic value of liver fatty acid-binding protein (FABPs) for impairment of renal function in type2 diabetic (T2D) patients